The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 7.65 million shares were traded. MPW stock price reached its highest trading level at $4.625 during the session, while it also had its lowest trading level at $4.55.
Ratios:
For a deeper understanding of Medical Properties Trust Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.74. For the most recent quarter (mrq), Quick Ratio is recorded 2.76 and its Current Ratio is at 2.76. In the meantime, Its Debt-to-Equity ratio is 2.00 whereas as Long-Term Debt/Eq ratio is at 2.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Exane BNP Paribas on March 12, 2025, Upgraded its rating to Outperform and sets its target price to $9 from $5 previously.
On September 13, 2024, Colliers Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $6.50. Exane BNP Paribas Downgraded its Outperform to Neutral on July 02, 2024, while the target price for the stock was maintained at $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 05 ’25 when Stewart Michael G sold 29,000 shares for $5.20 per share. The transaction valued at 150,800 led to the insider holds 216,100 shares of the business.
Stewart Michael G bought 29,000 shares of MPW for $150,800 on May 05 ’25. On Mar 05 ’25, another insider, Hanna James Kevin, who serves as the Senior VP, Controller & CAO of the company, bought 7,411 shares for $5.75 each. As a result, the insider paid 42,613 and bolstered with 372,338 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MPW now has a Market Capitalization of 2771071232 and an Enterprise Value of 11911331840. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.01 while its Price-to-Book (P/B) ratio in mrq is 0.57. Its current Enterprise Value per Revenue stands at 12.096 whereas that against EBITDA is 18.212.
Stock Price History:
The Beta on a monthly basis for MPW is 1.41, which has changed by -0.27629513 over the last 52 weeks, in comparison to a change of 0.17089343 over the same period for the S&P500. Over the past 52 weeks, MPW has reached a high of $6.55, while it has fallen to a 52-week low of $3.51. The 50-Day Moving Average of the stock is 8.19%, while the 200-Day Moving Average is calculated to be -1.58%.
Shares Statistics:
For the past three months, MPW has traded an average of 8.63M shares per day and 7318900 over the past ten days. A total of 600.81M shares are outstanding, with a floating share count of 495.75M. Insiders hold about 17.53% of the company’s shares, while institutions hold 58.10% stake in the company. Shares short for MPW as of 1756425600 were 166289061 with a Short Ratio of 19.26, compared to 1753920000 on 173768048. Therefore, it implies a Short% of Shares Outstanding of 166289061 and a Short% of Float of 39.720002.
Dividends & Splits
According to the company, the forward annual dividend rate for MPW is 0.32, from 0.32 in the trailing year. Against a Trailing Annual Dividend Yield of 0.07064017The stock’s 5-year Average Dividend Yield is 9.97.
Earnings Estimates
The dynamic stock of Medical Properties Trust Inc (MPW) is currently being evaluated by a team of 6.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.03, with high estimates of $0.06 and low estimates of $0.02.
Analysts are recommending an EPS of between $0.24 and -$0.32 for the fiscal current year, implying an average EPS of -$0.2. EPS for the following year is $0.12, with 1 analysts recommending between $0.12 and $0.12.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $247.27M this quarter.It ranges from a high estimate of $272.36M to a low estimate of $235.8M. As of the current estimate, Medical Properties Trust Inc’s year-ago sales were $225.83MFor the next quarter, 5 analysts are estimating revenue of $250.02M. There is a high estimate of $273.66M for the next quarter, whereas the lowest estimate is $236.85M.
A total of 6 analysts have provided revenue estimates for MPW’s current fiscal year. The highest revenue estimate was $1.09B, while the lowest revenue estimate was $932.6M, resulting in an average revenue estimate of $974.44M. In the same quarter a year ago, actual revenue was $995.55MBased on 7 analysts’ estimates, the company’s revenue will be $1.03B in the next fiscal year. The high estimate is $1.1B and the low estimate is $981.14M.
